Background/Aim: Individualization of treatment may improve the outcome of patients with
bone metastases from breast cancer. To support physicians when selecting individualized …

For prognostic assessment in women who receive radiotherapy (RT) for bone metastases
(BMs) from breast cancer (BC), prognostic factors specific for BMs from BC were investigated …

Background The study evaluates the frequency of and indications for bone-metastases (BM)-
related surgery and/or radiotherapy in the palliative breast cancer (BC) situation and …

Skeletal morbidity is common in patients with bone metastases from breast cancer (BC) and
can undermine patients' functional independence and quality of life. Previously defined …

Bone metastases from breast cancer can cause clinically relevant skeletal morbidity. These
skeletal-related events (SREs) can undermine patient quality of life and functional …

Purpose: Recent developments in the treatment for early bone metastases (BM) requires
better understanding of the metastatic distribution, incidence, and timing of bone …

Background/Aim: Patients with bone-only metastases survive longer than patients with
widespread visceral disease. We analyzed the prognostic impact of different baseline …

e12011 Background: Breast cancer is mostly diagnosed in elderly women aged>= 65 years
and they constitute about 41% of all newly diagnosed cases. Bone metastases is a very …

Bone is the most common of breast cancer metastasis. Bone metastasis causes skeletal-
related events (SREs), including pain, bone fractures, spinal cord compression, and …

Bone metastases (BM) represent the most frequent indication for palliative radiotherapy in
patients with breast cancer. BM increase the risk of skeletalrelated events defined as …